Erytech Pharma SA Buy Hold or Sell Recommendation
| ERYPDelisted Stock | USD 0.78 0.04 4.88% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Erytech Pharma SA is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Erytech Pharma SA given historical horizon and risk tolerance towards Erytech Pharma. When Macroaxis issues a 'buy' or 'sell' recommendation for Erytech Pharma SA, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. Note, we conduct extensive research on individual companies such as Erytech and provide practical buy, sell, or hold advice based on investors' constraints. Erytech Pharma SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
Erytech |
Execute Erytech Pharma Buy or Sell Advice
The Erytech recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Erytech Pharma SA. Macroaxis does not own or have any residual interests in Erytech Pharma SA or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Erytech Pharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Erytech Pharma Trading Alerts and Improvement Suggestions
| Erytech Pharma SA is not yet fully synchronised with the market data | |
| Erytech Pharma SA has some characteristics of a very speculative penny stock | |
| Erytech Pharma SA has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (228 K) with profit before overhead, payroll, taxes, and interest of 4.18 M. | |
| Erytech Pharma SA currently holds about 54.05 M in cash with (31.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.74, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Erytech Pharma Returns Distribution Density
The distribution of Erytech Pharma's historical returns is an attempt to chart the uncertainty of Erytech Pharma's future price movements. The chart of the probability distribution of Erytech Pharma daily returns describes the distribution of returns around its average expected value. We use Erytech Pharma SA price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Erytech Pharma returns is essential to provide solid investment advice for Erytech Pharma.
| Mean Return | -0.08 | Value At Risk | -8.25 | Potential Upside | 12.68 | Standard Deviation | 7.09 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Erytech Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Erytech Pharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Erytech . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Erytech Pharma Buy or Sell Advice
When is the right time to buy or sell Erytech Pharma SA? Buying financial instruments such as Erytech Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Erytech Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run USD Crypto Fund Thematic Idea Now
USD Crypto Fund
Fund from digital currency traded on multiple global exchanges in US dollors. The USD Crypto Fund theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize USD Crypto Fund Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Erytech Stock
If you are still planning to invest in Erytech Pharma SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Erytech Pharma's history and understand the potential risks before investing.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |